Yu-Chen Wu

Experience: Private Equity Funds: Represented a United States-focused private equity sponsor in forming Delaware and Cayman funds for investing in real estate.; Represented a Taiwan-headquartered private equity sponsor in forming a project fund for investing in technology and semiconductor equipment companies in Southeast Asia.; Advised a number of Taiwan-headquartered private equity sponsors on ongoing legal and compliance matters, including matters related to partnership agreements and side letters, excused investments, successor funds, continuation funds, alternative and parallel vehicles, securing fund financing facilities and conflicts of interest, among others.; Other Cross-Border Transactions: Represented a Shanghai-based operator of rental apartments in China (a portfolio company of a premier global private equity firm headquartered in New York) in its prospective listing on the Hong Kong Stock Exchange.; Represented ADICON Holdings Limited (HKSE: 9860) (a portfolio company of Carlyle) in its listing on the Hong Kong Stock Exchange.; Represented ADICON Holdings Limited as local counsel in its acquisition of Crown Bioscience International.; Represented a Taiwan-headquartered private equity fund in its investment into a renowned restaurant group with presence in the United States and Europe.; Represented a U.S.-focused private equity fund in its SAFE investment into a Singaporean AI company.; Represented a reputable Taiwanese motor company and its affiliated private equity arm in selling their respective stakes in a Singaporean multinational technology group.; The above selected representations were handled by Ms. Wu prior to her joining Greenberg Traurig Singapore LLP.